BioCentury | Feb 18, 2008
Company News

Archemix, NascaCell deal

...The companies expanded their 2003 deal to give NascaCell non-exclusive rights to use Archemix’s aptamer technology...
...to contract NascaCell to generate aptamers for Archemix’s own applications. Archemix Corp. , Cambridge, Mass. NascaCell GmbH...
BioCentury | Oct 15, 2007
Company News

Boehringer Ingelheim, NascaCell Technologies AG deal

...NascaCell will generate Microbodies against up to four undisclosed targets provided by Boehringer. NascaCell will receive...
...using NascaCell's Microbody technology. Further terms were not disclosed. Boehringer Ingelheim GmbH , Ingelheim, Germany NascaCell...
BioCentury | Jan 22, 2007
Strategy

Aptamer family tree

...to Eyetech, now part of OSI (OSIP). Archemix later licensed certain aptamer rights to Noxxon, NascaCell...
BioCentury | Jan 22, 2007
Company News

NascaCell Technologies AG board of directors update

NascaCell Technologies AG , Munich, Germany Business: Supply/Service Appointed: Manfred Zoltobrocki, former CEO of Epidauros Biotechnologie AG ; he replaces Christoph Ofele WIR Staff...
BioCentury | Jun 19, 2006
Company News

NascaCell Technologies AG, Technical University deal

...acids in length. NascaCell said Microbodies inhibit intracellular signal transduction and down-regulate certain metabolic proteins. NascaCell...
BioCentury | Jun 5, 2006
Company News

NascaCell Technologies AG, Bayer deal

...subsidiary (Monheim, Germany) will use to validate crop science targets. Further terms were not disclosed. NascaCell...
BioCentury | Feb 6, 2006
Company News

NascaCell IP GmbH management update

NascaCell IP GmbH , Munich, Germany Business: Chemistry Promoted: Michael Blind to CEO from CBO WIR Staff Ophthalmic...
BioCentury | Feb 6, 2006
Company News

Kinaxo management update

...Biotechnologies GmbH , Martinsried, Germany Business: Supply/Service Hired: Andreas Jenne as CEO, formerly CEO of NascaCell...
BioCentury | Jan 31, 2006
Company News

Kinaxo names Jenne CEO

...Kinaxo (Martinsried, Germany) hired Andreas Jenne as CEO. Previously, Jenne was CEO of aptamer company NascaCell...
BioCentury | Apr 18, 2005
Company News

NascaCell, PSF Biotech, Xantos deal

...and small molecule screening technology, PSF's protein production and crystallization capabilities and NascaCell's aptamer technology. NascaCell GmbH...
Items per page:
1 - 10 of 21
BioCentury | Feb 18, 2008
Company News

Archemix, NascaCell deal

...The companies expanded their 2003 deal to give NascaCell non-exclusive rights to use Archemix’s aptamer technology...
...to contract NascaCell to generate aptamers for Archemix’s own applications. Archemix Corp. , Cambridge, Mass. NascaCell GmbH...
BioCentury | Oct 15, 2007
Company News

Boehringer Ingelheim, NascaCell Technologies AG deal

...NascaCell will generate Microbodies against up to four undisclosed targets provided by Boehringer. NascaCell will receive...
...using NascaCell's Microbody technology. Further terms were not disclosed. Boehringer Ingelheim GmbH , Ingelheim, Germany NascaCell...
BioCentury | Jan 22, 2007
Strategy

Aptamer family tree

...to Eyetech, now part of OSI (OSIP). Archemix later licensed certain aptamer rights to Noxxon, NascaCell...
BioCentury | Jan 22, 2007
Company News

NascaCell Technologies AG board of directors update

NascaCell Technologies AG , Munich, Germany Business: Supply/Service Appointed: Manfred Zoltobrocki, former CEO of Epidauros Biotechnologie AG ; he replaces Christoph Ofele WIR Staff...
BioCentury | Jun 19, 2006
Company News

NascaCell Technologies AG, Technical University deal

...acids in length. NascaCell said Microbodies inhibit intracellular signal transduction and down-regulate certain metabolic proteins. NascaCell...
BioCentury | Jun 5, 2006
Company News

NascaCell Technologies AG, Bayer deal

...subsidiary (Monheim, Germany) will use to validate crop science targets. Further terms were not disclosed. NascaCell...
BioCentury | Feb 6, 2006
Company News

NascaCell IP GmbH management update

NascaCell IP GmbH , Munich, Germany Business: Chemistry Promoted: Michael Blind to CEO from CBO WIR Staff Ophthalmic...
BioCentury | Feb 6, 2006
Company News

Kinaxo management update

...Biotechnologies GmbH , Martinsried, Germany Business: Supply/Service Hired: Andreas Jenne as CEO, formerly CEO of NascaCell...
BioCentury | Jan 31, 2006
Company News

Kinaxo names Jenne CEO

...Kinaxo (Martinsried, Germany) hired Andreas Jenne as CEO. Previously, Jenne was CEO of aptamer company NascaCell...
BioCentury | Apr 18, 2005
Company News

NascaCell, PSF Biotech, Xantos deal

...and small molecule screening technology, PSF's protein production and crystallization capabilities and NascaCell's aptamer technology. NascaCell GmbH...
Items per page:
1 - 10 of 21